Endolymphatic Hydrops Grade M2 Correlates Most Strongly With Hearing Loss
THURSDAY, June 1, 2023 (HealthDay News) -- M2 grading of intracochlear endolymphatic hydrops shows the strongest correlation with hearing loss with Meniere disease, according to a study published online May 17 in Acta Oto-Laryngologica.
Zhihao Han, from the Capital Medical University in Beijing, and colleagues compared the grading consistency and correlation between different grade methods of intracochlear endolymphatic hydrops and hearing loss. The analysis included 31 patients diagnosed with Meniere disease who underwent gadolinium-enhanced magnetic resonance imaging.
The researchers found that the weighted kappa coefficients for interobserver and intraobserver agreements for grading cochlea endolymphatic hydrops using M1 were good, while they were excellent for M2, M3, and M4. Based on M2 cochlear endolymphatic hydrops degree, there was correlation with the low-to-mid frequencies, high frequencies, full frequencies, and Meniere disease clinical stage. For degrees based on M1, M3, and M4, correlations were only relevant for some of the four factors.
"In this study, we summarized the four currently prevailing methods to assess cochlear endolymphatic hydrops. Furthermore, we compared the interobserver and intraobserver agreements of the different methods," the authors write. "The results showed that M2 performed better than the other three methods. Therefore, we recommend the use of M2 for evaluating cochlear endolymphatic hydrops."
Related Posts
Los tratamientos antivirales deberían funcionar bien contra la ómicron, aseguran los expertos
VIERNES, 10 de diciembre de 2021 (HealthDay News) -- La variante ómicron podría...
Un nuevo fármaco reduce a la mitad las muertes entre los que tienen una COVID grave, afirma el fabricante
MARTES, 12 de abril de 2022 (HealthDay News) -- Un medicamento experimental para...
La vacuna contra la COVID de tres dosis de Pfizer provoca una fuerte respuesta en los niños más pequeños
LUNES, 23 de mayo de 2022 (HealthDay News) -- Pfizer/BioNTech afirma que un...
Women Have Higher Tau, Especially in Setting of Elevated Aβ
WEDNESDAY, April 5, 2023 (HealthDay News) -- Women have higher tau than men,...